MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE

Clinical trials for MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE trials appear

Sign up with your email to follow new studies for MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New drug aims to break down Alzheimer's brain clumps

Disease control Ongoing

This study is testing whether a new drug called PRI-002 is safe and can help people with early-stage Alzheimer's disease. The drug is designed to break apart harmful clumps of protein in the brain that are thought to cause memory and thinking problems. About 304 people with mild …

Matched conditions: MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE

Phase: PHASE2 • Sponsor: PRInnovation GmbH • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE

Get alerted when new MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE trials appear

New drug aims to break down Alzheimer's brain clumps